Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008
A 56-year-old woman with a poorly differentiated endometrioid adenocarcinoma and peritoneal carcinomatosis was treated with pegylated liposomal doxorubicin for disease progression. After the second dose (40 mg/m2), she developed an eruption that consisted of erythematous plaques with areas of exfoliation and superficial erosions localized to the axillary and submammary areas (Figure 1), groin, hands, and feet. She did not present with hand-foot syndrome.
Garcia-Navarro X, Puig L, Fernández-Figueras MT, Alomar A. Eccrine Squamous Syringometaplasia Secondary to Pegylated Liposomal Doxorubicin. Arch Dermatol. 2008;144(10):1402–1403. doi:10.1001/archderm.144.10.1402
Customize your JAMA Network experience by selecting one or more topics from the list below.